Bifonazole (Mycospor® cream) in the treatment of moccasin-type tinea pedis. Comparison between combination therapy of bifonazole cream + 10% urea ointment (Urepearl®) and occlusive dressing therapy with the same agents

Mycoses

Volumn 43, Issue 3-4, 2000, Pages 129-137

  Tanuma, H ^a   Doi, M ^a   Sato, N ^a   Nishiyama, S ^a   Abe, M ^a   Kume, H ^a   Katsuoka, K ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antimycotic chemotherapy; Bifonazole; Combination therapy; Moccasin type; Occlusive dressing; Tinea pedis; Urea ointment

Indexed keywords

BIFONAZOLE; PASTARON; UREA; ANTIFUNGAL AGENT; IMIDAZOLE DERIVATIVE;

ADULT; AGED; ARTICLE; BLISTER; CLINICAL ARTICLE; CREAM; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; OINTMENT; PRIORITY JOURNAL; PRURITUS; TINEA PEDIS; WOUND DRESSING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROTECTIVE CLOTHING; TIME; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTIFUNGAL AGENTS; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; OCCLUSIVE DRESSINGS; OINTMENTS; TIME FACTORS; TINEA PEDIS; UREA;

EID: 0033624102     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.2000.00560.x     Document Type: Article

References (12)

1. 1 Tanuma, H. (1995) Treatment of hyperkeratotic type tinea pedis. Rinsho Derma Tokyo 37, 1939-1946.
2. 2 Tanuma, H. and Nishiyama, S. (1997) Clinical evaluation of bifonazole (Mycospor® solution) for moccasin type tinea pedis-comparison with 1% bifonazole solution plus 10% urea ointment. Mycoses 40, 223-228.
3. 3 Tanuma, H., Doi, M., Yaguchi, A., et al. (1998) Efficacy of oral fluconazole in tinea pedis of the hyperkeratotic type. Stratum corneum levels. Mycoses 41, 153-162.
4. 4 Tanuma, H. (1999) Pathogenesis and treatment of hyperkeratotic tinea pedis in Japan. Mycoses 42, 21-28.
5. 5 Tanuma, H., Doi, M., Ohta, Y. et al. (2000) Usefulness of 1% terbinafme HCl (Lamisil®) cream for hyperkeratotic-type tinea pedis and its transfer into the horny layers. Mycoses 43, 00-00. in press.
6. 6 Greer, D. (1987) Topical treatment for moccasin-type tinea pedis. J. Am. Acad. Dermatol. 16, 554-558.
7. 7 Savin, R. C. and Zaias, N. (1990) Treatment of chronic moccasin type tinea pedis with terbinafine. A double-blind, Placebo-controlled trial. J. Am. Acad. Dermatol. 23, 804-807.
8. 8 Savin, R. C., Atton, A. V., Bergstresser, P. R., Elewski, B., Jones, H. E. and Levine, N. (1994) Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: result of placebo-controlled multicenter trials. J. Am. Acad. Dermatol. 30, 663-667.
9. 9 Plempel, M. and Regel, E. (1982) Antimycotic properties of the topical azole bifonazole in vitro and in vivo. Excepta Medica, Tokyo. XX, 29-36.
10. 10 Plempel, M. (1982) Bifonazole-clotrimazole comparison of the properties and in actions in vitro and in vivo. Bayer's in-house data, p 6.
11. 14C) bifonazole in man. Arzneimittelforschung 33, 745-750.
12. 12 Nishimoto, K. and Honma, K. (1986) Comparation study between potassium hydroxide mount and culture examination during the treatment of dermatophytes and candidasis. Jpn J. Med. Mycol. 27, 119-123.